Barclays’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-75,000
Closed -$2.15M 5466
2025
Q2
$2.15M Buy
+75,000
New +$2.23M ﹤0.01% 2789
2020
Q3
Sell
-5,500
Closed -$107K 5184
2020
Q2
$107K Sell
5,500
-3,000
-35% -$48.7K ﹤0.01% 4467
2020
Q1
$123K Buy
8,500
+4,700
+124% +$83.9K ﹤0.01% 4649
2019
Q4
$78K Sell
3,800
-1,400
-27% -$27.8K ﹤0.01% 5586
2019
Q3
$101K Sell
5,200
-34,900
-87% -$759K ﹤0.01% 5465
2019
Q2
$904K Buy
40,100
+25,800
+180% +$707K ﹤0.01% 3780
2019
Q1
$522K Buy
14,300
+1,800
+14% +$59.4K ﹤0.01% 4072
2018
Q4
$369K Buy
12,500
+11,300
+942% +$416K ﹤0.01% 4088
2018
Q3
$51K Sell
1,200
-2,800
-70% -$122K ﹤0.01% 6069
2018
Q2
$165K Buy
4,000
+1,100
+38% +$50.1K ﹤0.01% 4874
2018
Q1
$168K Sell
2,900
-1,400
-33% -$81.9K ﹤0.01% 4975
2017
Q4
$235K Sell
4,300
-4,300
-50% -$219K ﹤0.01% 4556
2017
Q3
$437K Buy
8,600
+1,600
+23% +$85.6K ﹤0.01% 3753
2017
Q2
$406K Sell
7,000
-24,800
-78% -$1.44M ﹤0.01% 3723
2017
Q1
$1.86M Sell
31,800
-1,700
-5% -$96.4K ﹤0.01% 2162
2016
Q4
$1.86M Buy
33,500
+32,800
+4,686% +$1.75M ﹤0.01% 2187
2016
Q3
$33K Sell
700
-7,500
-91% -$357K ﹤0.01% 5215
2016
Q2
$354K Sell
8,200
-3,300
-29% -$136K ﹤0.01% 3487
2016
Q1
$391K Buy
11,500
+8,700
+311% +$344K ﹤0.01% 3334
2015
Q4
$221K Buy
2,800
+200
+8% +$14K ﹤0.01% 3826
2015
Q3
$151K Sell
2,600
-8,200
-76% -$541K ﹤0.01% 4332
2015
Q2
$691K Sell
10,800
-2,600
-19% -$159K ﹤0.01% 3202
2015
Q1
$804K Buy
13,400
+9,100
+212% +$622K ﹤0.01% 3173
2014
Q4
$249K Sell
4,300
-18,600
-81% -$947K ﹤0.01% 4452
2014
Q3
$962K Sell
22,900
-4,500
-16% -$202K ﹤0.01% 3394
2014
Q2
$1.37M Buy
27,400
+24,200
+756% +$1.12M ﹤0.01% 3016
2014
Q1
$141K Sell
3,200
-7,000
-69% -$333K ﹤0.01% 5119
2013
Q4
$408K Buy
+10,200
New +$377K ﹤0.01% 4301
2013
Q3
Sell
-28,200
Closed -$809K 7374
2013
Q2
$809K Buy
+28,200
New +$822K ﹤0.01% 3660

Other funds holding ALKS

Barclays's ALKS Position: Q1 2026 in Review

Barclays reduced its Alkermes (ALKS) stake by 69% in Q1 2026, selling an estimated $12.1M and leaving 174,983 shares worth $6.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Barclays first reported a position in ALKS in Q2 2013 and has held it in 51 quarters since. The position peaked at $19.9M in Q2 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Barclays held 174,983 shares of Alkermes worth $6.19M as of Q1 2026.
  • Barclays sold 390,050 Alkermes shares in Q1 2026, an estimated $12.1M.
  • Alkermes made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1692 holding.
  • Barclays first reported a position in Alkermes in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Alkermes position peaked at $19.9M in Q2 2025.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.